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There is, at present, a clear and recognised need to optimise 
the diagnosis of peripheral arterial disease (PAD), particu-
larly in non-specialist settings such as primary care, and this 
arises from several key facts. First, PAD is a highly prevalent 
condition; in 2010, it was estimated that globally, it affected 
more than 202 million people and furthermore, this preva-
lence is predicted to further escalate.1 The disease itself, 
although frequently asymptomatic, can cause considerable 
patient suffering with symptoms such as lower limb pain, 
ulceration and gangrene which, in worse-case scenarios, can 
necessitate limb amputation. A further and perhaps the most 
eminent consequence of PAD arises from the fact that it is a 
manifestation of systemic atherosclerosis and therefore is a 
powerful predictor of coronary heart disease and cerebrovas-
cular disease.2 Multiple longitudinal studies have demon-
strated that PAD (both asymptomatic and symptomatic) has 
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been associated with a three to sixfold increased risk of death 
from cardiovascular causes.3
PAD, however, is frequently asymptomatic, particularly 
in those less mobile and therefore is under-diagnosed;4 hence 
it has been termed ‘a silent but lethal epidemic’.5 This has 
resulted in calls for the instigation of primary care PAD 
screening which would identify those at increased risk and 
potentially allow alteration of the disease trajectory via sec-
ondary risk factor modification.6
The ankle brachial index (ABI) has been the foundation 
of non-invasive PAD diagnosis for several decades, hence 
making it seemingly pivotal to any primary care PAD screen-
ing strategy. However, studies have demonstrated that the 
ABI has not been readily adopted by primary care clinicians 
and that it is, in fact, infrequently and often incorrectly uti-
lised in non-specialist healthcare settings.7,8 Lack of knowl-
edge and skills to undertake the procedure utilising a 
hand-held Doppler ultrasound probe and manual sphyg-
momanometer has been identified as a factor associated with 
this low use.9 In addition, the time-consuming nature of this 
method and the need to rest subjects for at least 10 min prior 
to the procedure also significantly limit its use in busy 
healthcare settings.7,8 In recent years, several manufacturers 
have developed automated ABI devices which aim to address 
such issues by negating the need for both operator skill and a 
rest period. Research investigating whether such devices 
have sufficient diagnostic accuracy to replace the traditional 
Doppler method has proven inconclusive.10
A further, well-recognised limitation of the ABI is that it 
can become artefactually elevated and non-diagnostic in cer-
tain patient groups such as diabetics, the elderly and those 
with renal disease. This therefore underlines the need for a 
secondary mode of assessment for the diagnosis of PAD. 
Pulse volume waveform (PVW) interpretation constitutes a 
further non-invasive, diagnostic procedure that can be uti-
lised to evaluate blood flow in the extremities. Its use is rec-
ommended by both the European Society of Cardiology and 
the American College of Cardiology/American Heart 
Association as a second-level assessment tool for patients 
with suspected PAD.2,11 It has been used in vascular labora-
tories for PAD assessment for several decades; however, 
recent technological advances have resulted in this modality 
becoming more amenable for use in other settings such as 
community and primary care. Interpretation of PVWs can be 
undertaken by visually comparing them to a four-level grad-
ing system (Figure 1).13 There is, however, limited evidence 
regarding the feasibility and practicality of incorporating this 
technology into routine, non-specialist practice.
Figure 1. Pulse volume waveform interpretation (according to four-level grading system).13
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The aims of this study were twofold: first, to evaluate the 
accuracy of the automated ABI measurement and PVW anal-
ysis for the diagnosis of PAD using duplex ultrasound scan-
ning as the reference standard and second, to consider the 
utility of a device which incorporates both automated ABI 
and PVW for use in the primary care setting.
Materials and method
This cross-sectional study recruited 205 consecutive patients 
who had been referred for lower limb arterial investigations 
to one of two medical physics/vascular outpatients depart-
ments within two UK teaching hospitals. Inclusion criteria 
included those referred for lower limb arterial investigations 
who were ⩾18 years of age and able to provide informed 
consent. Patients who had lymphoedema, thrombophlebitis 
or cellulitis were excluded from participation, as were those 
who were suspected as having a deep vein thrombosis (DVT) 
(current or in the preceding 6 months), those who had under-
gone bilateral mastectomy with lymph node removal, those 
with bilateral upper or lower limb amputation and those who 
were unable to lie supine. The study was approved by the 
Research Ethics Committee 2 (Cardiff, Wales, REC No: 13/
WA/0072) and written informed consent was gained from 
each participant.
Prior to the arterial assessment procedures, participants 
were asked to complete a brief questionnaire which captured 
basic demographic data (gender, age, smoking status), past 
medical history, family history of cardiovascular disease and 
reason for referral. Next, while supine, participants underwent 
ABI measurement using an automated device (Dopplex® 
ABIlity, DA100PB; Huntleigh Healthcare, Cardiff, UK), 
which utilises volume plethysmography to measure and calcu-
late the ABI and provides a paper printout of the PVW for 
Figure 2. Example of a results printout from the automated device.
Figure 3. Example of an ultrasound Duplex scan image.
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each leg (Figure 2); further detail of the device is provided in 
a previously published paper.12 The device was used in accord-
ance with the manufacturer’s guidelines and was operated by 
a podiatrist (J.E.A.L.) or vascular nurse practitioner (E.T.). 
J.E.A.L. subsequently graded the obtained PVWs according 
to Rumwell and McPharlin’s grading system (Figure 1).13
Duplex ultrasound scans of the lower limb arteries were 
then performed by a highly experienced medical physicist 
(P.W.), who was blinded to the ABI and PVW results (equip-
ment utilised: Toshiba Aplio 500 with linear PLT-704SBT 
and curvi-linear PVT-375BT probes). The participant again 
lay supine on the scanning couch with the lower limbs 
exposed. The distal common femoral artery (CFA) was 
imaged and the Doppler waveform (DW) was assessed visu-
ally for any loss of triphasic flow due to significant iliac dis-
ease. If the DW showed indications of this, then the iliac 
arteries were assessed for the presence of atherosclerotic dis-
ease. The scan continued distally from the CFA assessing the 
superficial femoral artery (SFA) and popliteal arteries in the 
longitudinal plane. The extent and severity of any arterial 
disease were assessed using triplex mode by measuring the 
peak systolic velocity (PSV) from the DW just proximal to 
and through the stenosis (Figure 3). Disease severity was 
classified using standard criteria outlined in Table 1.
For the purpose of this study, the results of each test for 
each limb were graded as ‘PAD present’ if ABI ⩽0.9; 
PVW = grade 2, 3 or 4 and duplex scan demonstrating ⩾50% 
stenosis.
Statistical analysis was undertaken using IBM SPSS soft-
ware (version 21; New York, USA). The sensitivity, specific-
ity, positive predictive value and negative predictive value of 
the ABI and PVW were calculated, against the duplex ultra-
sound scan results as the reference standard. A receiver oper-
ating characteristic (ROC) curve was utilised to further 
assess the accuracy of the ABI and to determine the optimal 
ABI cut-off point for the diagnosis of PAD. Agreement 
between the three tests was assessed using Cohen’s kappa.15 
Significance was set at p < 0.05.
Results
The flow charts of the study are shown in Figure 4(a) and (b) 
and participant demographics are presented in Table 2. Of 
the 189 participants who completed a full set of study meas-
urements, the mean age was 67 ± 12 years and 67% of the 
sample were male. In total, 36% of the participants were 
found to have PAD, in either one or both legs, as defined by 
the reference standard duplex ultrasound scan. PAD was 
found to be positively associated with male gender 
(p = 0.003), diabetes (p = 0.02), smoking history (p = 0.04), 
referral for leg pain (p = 0.01) and previously diagnosed PAD 
(p < 0.001) or vascular surgery (p < 0.001).
The sensitivity, specificity, positive predictive value, neg-
ative predictive value and overall accuracy of (1) the ABI, 
(2) PVW analysis and (3) ABI and PVW analysis combined, 
as compared to the ultrasound duplex scan (UDS) as the ref-
erence standard, are presented in Table 3. The distribution of 
ABI for the study population is shown in Figure 5.
Analysis of the ABI ROC curve (Figure 6) revealed an 
area under the curve (AUC) of 0.88 (95% confidence inter-
val (CI): 0.83–0.93, p < 0.001). The optimal ABI cut-off 
point for diagnosis of PAD was 0.98 which provided a sensi-
tivity of 87% and specificity of 80%.
Discussion
The ABI
Data suggest that the automated ABI has moderate sensitiv-
ity (79%) and good specificity (91%) for PAD diagnosis. 
ROC curve analysis and AUC of 0.89 also suggest a good 
degree of accuracy in comparison to duplex ultrasound 
results as the gold standard. The optimal cut-off point for 
diagnosis of PAD was 0.98 which is higher than the thresh-
old of 0.9 which is traditionally used for Doppler ABI meas-
urements. However, this appears to be a common finding 
associated with the use of automated ABI devices; a system-
atic review and meta-analysis of 25 studies which assessed 
the usefulness of oscillometric devices for ABI estimation 
compared to the conventional Doppler method also con-
cluded that to increase the sensitivity for PAD, a higher 
threshold ABI <1.0 might be preferable.10
Two factors could have contributed to the reduced sensi-
tivity of the ABI in this study; first, inaccuracies of the auto-
mated device itself could have played a part and second, it is 
possible that the demographics of the study population and 
the high likelihood of the presence of arterial calcification 
could have rendered the ABI non-diagnostic in a proportion 
of participants. In such cases, arterial calcification can arte-
factually raise ankle systolic pressures of PAD patients, 
which, in turn, results in the ABI being elevated to within the 
normal (>0.9–1.3) or high range (>1.3). Studies comparing 
Doppler ABI with UDS as the reference standard in diabetic 
populations also reported reduced sensitivities of 71%.16,17
The reported study is novel in design because it has uti-
lised UDS rather than the usual hand-held Doppler ABI 
method as the reference standard to evaluate the accuracy of 
an automated ABI device. There are therefore no data to 
Table 1. Grading of stenoses according to PSV ratio of 
velocities.14
PSV ratio % Stenosis PAD/no PAD
<2 Not haemodynamically 
significant
No PAD
2 50% (Moderate) PAD
>3 >70% (Tight) PAD
No colour flow Complete occlusion PAD
PSV: peak systolic velocity; PAD: peripheral arterial disease.
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Figure 4. (a) Flow diagram illustrating diagnostic accuracy of ABI as per Standards for Reporting Diagnostic Accuracy (STARD) and (b) 
flow diagram illustrating diagnostic accuracy of PVW as per Standards for Reporting Diagnostic Accuracy (STARD).
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which the current results can be directly compared. However, 
a recent study compared ABIs attained with the same auto-
mated ABI device (Dopplex ABIlity) to ABIs undertaken 
with a hand-held Doppler.17 The study population was of 
similar mean age (64 years) but did not contain any diabetics; 
it also returned a moderate sensitivity of 70% and good spec-
ificity of 96%.
PVW interpretation
The data suggest that analysis of the PVW has excellent sen-
sitivity (97%) and moderate specificity (81%) for PAD diag-
nosis. Research regarding PVW analysis for the identification 
of PAD is sparse, hence meaning that, again, there are little 
data available for comparative purposes. A study by Ro 
et al.18 evaluated the sensitivity and specificity of the ABI 
and subjective PVW analysis derived by photoplethysmog-
raphy (PPG), with subjective DW analysis compared to the 
gold standard of computed tomography angiography (CTA) 
diagnosed PAD. The test results from a total of 97 patients 
(194 legs) who had coincidently undergone CTA, ABI, PPG 
and DW were retrospectively reviewed. PVWs and DWs 
were subjectively interpreted by a single physician. With 
PVWs, diagnosis of PAD was based on loss of the dicrotic 
notch, decreased waveform amplitude and/or rounding of 
systolic peaks. For DWs, diagnosis of PAD was based on 
loss of triphasic pattern, decreased amplitude and/or loss of 
reverse flow component. The sensitivity and specificity of 
PPG PVW analysis compared to the CTA were 82% and 
77%, respectively; for DW analysis, sensitivity was 91% and 
Table 2. Population demographics.
All 
(n=189)
PAD status according to duplex p
 PAD (n=68) Non-PAD (n=121)
ABI (mean±SD) 1.0±0.22 0.72±0.12 1.12±0.14 <0.01*
Range 0.29–1.57 0.29–1.44 0.91–1.57  
Age (mean±SD)  67±12   69±10   66±12 0.108*
Gender (M:F) 65:35 79:21 63:37 0.003†
Hypertensive (%) 63 64 60 0.57†
Hyperlipidaemia (%) 57 59 54 0.38†
Previous CVA (%) 13 18 11 0.09†
Family history of CVA (%) 24 30 21 0.07†
Known CHD (%) 31 27 28 0.84†
Family history of CHD (%) 50 46 51 0.34†
Known PAD (%) 26 42 16 <0.01†
Family history of PAD (%) 15 10 16 0.20†
Diabetes (%) 26 18 30 0.02†
DVT history (%) 8 3 7 0.16†
Retinopathy (%) 5 4 6 0.50†
Smoker (%) 31 40 29 0.05†
Previous vascular surgery (%) 30 40 24 0.01†
C/o leg pain (%) 86 95 82 <0.01†









B, C or D) 
(n=175 limbs)
Combined (ABI⩽0.9 and/
or PVW grade B, C or D) 
(n=189 limbs)
Sensitivity (%) 79 97 100
Specificity (%) 91 81 76
Positive predictive value (%) 76 65 71
Negative predictive value (%) 92 99 100
Overall accuracy (%) 88 85 85
ABI: ankle brachial index; PVW: pulse volume waveform.
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specificity 65%, and for ABI sensitivity was 70% and speci-
ficity 97%. The authors concluded that ABI should be com-
bined with PVW analysis or DW analysis in order to improve 
detection of PAD.
PVW analysis versus DW analysis
Some clinicians may be more accustomed to analysing DWs 
which can often be viewed on a visual display unit incorpo-
rated into the hand-held Doppler; it is therefore useful to 
make a comparison of this with PVW analysis. The process 
of obtaining a PVW recording does not require operator skill 
and merely involves the application of a cuff to the foot or 
ankle; the device then automatically inflates, obtains and dis-
plays the PVW. The process of obtaining a DW is, in con-
trast, operator dependent where a Doppler probe has to be 
carefully positioned over an artery, at a specific angle and 
pressure; the results can vary with the Doppler angle used.19
Limitations of PVW analysis
There are recognised physiological limitations related to 
PVW analysis. First, the PVW is dependent on peripheral 
blood flow and thus may be influenced by factors other than 
vessel patency such as sympathetic nerve input.20 Second, 
severe congestive heart failure may also slow blood flow and 
mimic inflow disease.21 Third, the PVW represents the total 
blood flow through the area being assessed and cannot there-
fore provide accurate diagnostic information as to what 
extent a specific artery is diseased.
Combining the ABI and PVW analysis
Combining the ABI and PVW results for each participant, 
where if either the ABI or the PVW analysis returned a posi-
tive result for either leg, then the participant was classed as 
having PAD, returned a sensitivity of 100%, specificity of 
76% and overall accuracy of 85%. The negative predictive 
value of combining these diagnostic modalities was 100% 
meaning that the dual diagnostic device (Dopplex ABIlity) 
utilised within this study can rule out PAD with a high degree 
of accuracy (as defined by both ABI and PVW analysis 
returning negative results).
Utility within primary care
Utilisation of this device in the primary care setting, apply-
ing the criteria that double negative results (from the ABI 
and PVW analysis) do not require secondary care assess-
ment would have prevented 46% (93/202) of referrals to the 
vascular laboratory for the population of this study, and 
importantly, no cases of PAD would have been missed. An 
audit by Poots et al. of 451 patients referred to a vascular 
clinic revealed that a similar proportion of referrals (41%) 
were deemed inappropriate as subsequent Doppler assess-
ment revealed normal ABIs and normal triphasic Doppler 
signals.22
Study strengths and limitations
Strengths. The large sample size and high-risk study popula-
tion with multiple co-morbidities serve to optimise the clini-
cal relevance of this study. Furthermore, the majority of the 
existing studies evaluating automated ABI devices utilise 
Doppler ABI as the reference standard, which itself is opera-
tor dependent and with the process susceptible to inherent 
Figure 5. Distribution of ABIs.
Figure 6. Receiver operating characteristic (ROC) curve for 
automated ABI device in diagnosing PAD as defined by ultrasound 
duplex scan. Area under curve=0.88 (95% CI: 0.83–0.93, 
p<0.001).
ABI: ankle brachial index; CI: confidence interval; PAD: peripheral arterial 
disease.
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error. This study has utilised UDS which is recognised as the 
superior non-invasive modality which can diagnose PAD 
with a high degree of accuracy.23
Limitations. This study has evaluated the utility of subjective 
PVW analysis when undertaken by a single clinician who 
has experience and a personal interest in the procedure; find-
ings are not therefore representative of how less experienced, 
non-specialist clinicians would perform.
Conclusion
Within this study population, PVW analysis provided excel-
lent sensitivity for the detection of PAD while the ABI pro-
vided very good specificity. Combining these two diagnostic 
modalities within one device provided a highly accurate 
method of ruling out PAD. Hence, this suggests that this 
device could be utilised within the primary care environment 
to reduce the number of unnecessary referrals to secondary 
care with concomitant cost savings, reduced patient inconven-
ience and prioritisation of urgent PAD cases. Future research 
should investigate ease of use of PVW analysis, along with the 
cost and training required to achieve reliable results.
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